Case Conference 02/14/2014 Yuvaraj Thangaraj , MD Nephrology Fellow
description
Transcript of Case Conference 02/14/2014 Yuvaraj Thangaraj , MD Nephrology Fellow
CASE CONFERENCE 02/14/2014
Yuvaraj Thangaraj, MDNephrology FellowDivision of Nephrology ,HTN and Renal Transplantation
HISTORY OF PRESENT ILLNESS
24 y/o male with PMH significant for opioid abuse(iv drug user), tobacco abuse presented to OSH with symptoms of 20 pound weight loss, progressive fatigue, N/V for several weeks duration and 1 episode of hematuria
He was found to have a creatinine of 11, BUN 105, Hemoglobin 7
UA showed microscopic hematuria and Ultrasound showed increased echogenicity and no evidence of Hydronephrosis
ANA : mildly positive, ANCA 1:20 positive, SPEP and UPEP negative
No protein quantification done
He was started on HD for solute clearance and volume management
Noted to have enterococcus in blood culture and urine culture
TTE showed good valvular and left ventricular function
Biopsy showed pauci-immune necrotizing crescentic GN
RENAL BIOPSY
Multiple levels with H&E, PAS and PAMS stainswere evaluated. Sections contain18 glomeruli. Three are globally sclerotic. All but two others shownecrosis and/or crescents. The capillaries are notgenerally patent with marked collapse and necrosis. The tubules showsevere atrophy and focal destruction. There issevere interstitial fibrosis and chronic inflammation. Medium sizedarteries show fibrinoid necrosis, endarteritis andexoarteritis. Attached EM and IF files show pauci-immuneglomerulonephritis.
PMH
1)IV Drug abuse2)Tobacco abuse3)Opioid abuse
PSH
None
FH
None significant
ALLERGY
None
REVIEW OF SYSTEMS
20 lb weight loss
Fatigue
Nausea
Vomiting
Poor appetite
Hematuria
Decreased urine output
PHYSICAL EXAM
Vital Signs:
BP: 137/91 mmHgTemp: 37.3 °C (99.1 °F)Pulse: 110 Resp: 18 SpO2: 95 %
Constitutional: young white male-Not in distressEyes: PERRLENT: No pharyngeal congestion/erythemaNeck : Trachea midline, R chest vascath without drainage or surrounding erythema CV: s1s2 positive, no m/r/gPulm: CTA B/L, no wheezes, rales or rhonchi, symmetric air entry GI: soft, abdominal wall edema, No tenderness Skin: No rashes or skin discolouration
RENAL FUNCTION PANEL CBC
URINALYSIS
SUMMARY
24 y/o male iv drug abuser presents with AKI
UA – microscopic hematuria
USG – increased echogenicity
ANA and ANCA - weekly positive
Renal biopsy - consistent with PNCGN
Blood culture and urine culture - positive for enterococcus
CLINICAL CONUNDRUM
Is this Pauci-immune Crescentic Necrotizing Vasculitis (PCNGN) or Infection Related Crescentic GN (IRGN) ?
How do we approach ?
Decreased Normal
Negative Positive
Crescents Crescents
positive negative
Infection Related-CrescenticGN
Pauci-immuneCrescenticGN
Complement
ANCA
Light microscopy
IF
EM Deposits No deposits
PATHOGENESIS OF IRGN
Ref : Comprehensive textbook of Nephrology, 4th edition: Richard J Johnson
PATHOGENESIS OF VASCULITIS
New pathophysiological insights and treatment of ANCA-associated vasculitisBenjamin Wilde, Pieter van Paassen, Oliver Witzke and Jan Willem Cohen Tervaert
A major differential diagnosis of IRGN and particularly infectious endocarditis–associated GN is ANCA-induced pauci-immune necrotizing and crescentic glomerulonephritis
Crescentic and necrotizing glomerulonephritis is the most common pattern of glomerular injury in patients with infectious endocarditis–associated GN
CONCLUSION
Infective endocarditis related GN is usually not associated with immune complex deposit
Infection related GN (other than Infective endocarditis related GN) is usually associated with immune complex deposit
Pauci-immune necrotizing GN is the most common pathologic finding in renal biopsy in IE
Opana ER is a recently reformulated extended-release form of oxymorphone (an opioid pain reliever) intended for oral
administration
Fourteen of the 15 patients reported injecting reformulated Opana ER
Seven patients were treated for sepsis
The new formulation contains inactive ingredients not found in the original formulation, including polyethylene oxide (PEO) and polyethylene glycol